{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-196112","form_type":"8-K","ticker":"VRCA","cik":"0001660334","company_name":"Verrica Pharmaceuticals Inc.","filed_at":"2023-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.756905+00:00","generated_at":"2026-06-13T00:36:00.341673+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Verrica posts updated corporate presentation; no specific material changes disclosed","bullets":["Company filed an updated corporate presentation on its website on July 27, 2023.","Presentation content was not fully provided in the filing; only a title page was available.","No financial results, guidance, or strategic updates were detailed in the 8-K or exhibit.","This is a routine Regulation FD disclosure with no new quantitative data for investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-196112","json":"https://secwatch.observer/filing/0001193125-23-196112.json","markdown":"https://secwatch.observer/filing/0001193125-23-196112.md","text":"https://secwatch.observer/filing/0001193125-23-196112.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523196112/0001193125-23-196112-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523196112/d523492d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T00:36:00.341673+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}